Skip to main content
CARMAT logo

CARMAT — Investor Relations & Filings

Ticker · ALCAR ISIN · FR0010907956 LEI · 969500ARXACM0P0KH333 PA Manufacturing
Open in API
Filings indexed 570 across all filing types
Latest filing 2024-02-22 Regulatory Filings
Country FR France
Listing PA ALCAR

About CARMAT

https://www.carmatsa.com/en/

CARMAT is a medical technology company that designs, develops, and markets the Aeson® total artificial heart. This bioprosthetic device provides a therapeutic solution for patients suffering from end-stage biventricular heart failure. Aeson® is designed to replace the native heart, primarily as a bridge to transplantation for eligible patients. A key feature of the device is its self-regulation capability, which uses embedded sensors and biocompatible materials to automatically adapt blood flow based on the patient's physiological needs, thereby mimicking the function of a natural heart.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and discusses an "update on the renegotiation of the repayment terms of its loans with its financial creditors." It details agreements in principle regarding loan rescheduling (EIB, PGEs with BNP Paribas and Bpifrance) and an extension of a standstill agreement. This content relates to the company's financing, debt structure, and capital management, but it is not a formal regulatory filing like a 10-K, nor is it a standard earnings release (ER). It is an announcement concerning capital structure and financing activities. Among the provided codes, 'Capital/Financing Update' (CAP) is the most appropriate fit for a press release detailing significant loan renegotiations and extensions of debt standstills, as these directly impact the company's capital structure and financial stability.
2024-02-22 English
Informations privilégiées / Autres communiqués
Capital/Financing Update Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and details negotiations and agreements in principle regarding the rescheduling of CARMAT's financial borrowings (PGE loans and EIB loan). It discusses extensions of 'standstill' periods and future financing needs. This content relates directly to the company's capital structure, debt management, and financing activities, which aligns best with the 'Capital/Financing Update' category. It is not a full annual report (10-K), an earnings release (ER), or a formal regulatory filing announcing the publication of another document (RPA/RNS), but rather a substantive update on financing terms.
2024-02-22 French
Inside Information / Other news releases
Report Publication Announcement Classification · 1% confidence The document is explicitly titled "PRESS RELEASE" and its primary content is the announcement of the indicative financial calendar for 2024, detailing dates for the 2023 Full-Year Results, Shareholders' Meeting, and 2024 Half-Year Results. This is not the actual financial report (10-K or IR), nor is it a transcript (CT) or a detailed presentation (IP). It is an announcement about future reporting events. Since it is a press release announcing future financial events/dates, it most closely aligns with an Earnings Release (ER) if it were announcing results, but here it is announcing the *schedule* of results. However, the closest fit among the options for a scheduled announcement regarding financial reporting dates, especially when it's a brief press release, is often the Earnings Release category if it were announcing results, or the general Regulatory Filings (RNS) if it's purely administrative. Given that it sets the schedule for key financial disclosures (Year-End Results, Half-Year Results), it functions as a preliminary announcement related to financial reporting cadence. Since there isn't a specific 'Calendar Announcement' code, and it's a formal press release announcing key dates, it is best classified as a general Regulatory Filing (RNS) or potentially an Earnings Release (ER) if we interpret it as the first step in the earnings cycle. Given the content is purely scheduling and not the results themselves, RNS is the most appropriate fallback for a non-standard announcement, though ER is often used broadly for earnings-related news. I will lean towards RNS as it is a general announcement of corporate events rather than the release of the actual results.
2024-02-05 English
Informations privilégiées / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is titled "COMMUNIQUE DE PRESSE" (Press Release) and its main purpose is to publish the "Agenda financier 2024" (2024 Financial Calendar). It explicitly lists dates for the 2023 Annual Financial Results, the Annual General Meeting (AGM), and the 2024 Half-Year Financial Results. Since this document is an announcement *about* future events and publications, and not the full report itself (like the 10-K or IR), it fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Given that it specifically announces the schedule for key financial and corporate events, RPA is the most precise fit, as it announces the publication of other reports. The document length (6188 chars) is substantial enough to be a detailed press release, but its function is purely informational regarding future dates, aligning with RPA.
2024-02-05 French
Inside Information / Other news releases
Capital/Financing Update Classification · 1% confidence The document is explicitly titled as a "PRESS RELEASE" and details the successful completion of a capital increase, including the gross amount raised (€16.5 million) and the allocation details. It discusses the use of proceeds, financing needs, and the resulting changes in share capital and voting rights, referencing a Prospectus approved by the AMF. This content directly relates to fundraising and capital structure changes. The most fitting category is 'Capital/Financing Update' (CAP). It is not a full Annual Report (10-K), an Earnings Release (ER), or a simple announcement of a report (RPA), as it contains the substantive details of the financing event itself.
2024-01-29 English
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 1% confidence The document is titled 'COMMUNIQUE DE PRESSE' (Press Release) and announces the successful completion of a capital increase ('augmentation de capital') for a gross amount of €16.5 M. It details the allocation of shares, the use of proceeds, and the resulting shareholder structure. This clearly relates to a financing activity or capital structure change. The definition for 'Capital/Financing Update' (CAP) fits this content perfectly, as it covers 'Updates on company fundraising, financing activities, or capital structure changes.' It is not a full annual report (10-K), an earnings release (ER), or a simple announcement of a report (RPA/RNS), but the primary subject is the capital raise itself.
2024-01-29 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.